GB2285218A - An aid to recovery from disease caused by bacteria fungi viruses and malignant cells - Google Patents
An aid to recovery from disease caused by bacteria fungi viruses and malignant cells Download PDFInfo
- Publication number
- GB2285218A GB2285218A GB9325804A GB9325804A GB2285218A GB 2285218 A GB2285218 A GB 2285218A GB 9325804 A GB9325804 A GB 9325804A GB 9325804 A GB9325804 A GB 9325804A GB 2285218 A GB2285218 A GB 2285218A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrogen peroxide
- mixture
- cells
- ascorbic acid
- healthy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 10
- 241000700605 Viruses Species 0.000 title claims description 10
- 241000894006 Bacteria Species 0.000 title claims description 9
- 230000003211 malignant effect Effects 0.000 title claims description 9
- 241000233866 Fungi Species 0.000 title claims description 7
- 238000011084 recovery Methods 0.000 title claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 84
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 76
- 239000000203 mixture Substances 0.000 claims abstract description 33
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 19
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 19
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 19
- 230000003647 oxidation Effects 0.000 claims abstract description 12
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 8
- 239000012528 membrane Substances 0.000 claims abstract 2
- 230000004060 metabolic process Effects 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 230000037406 food intake Effects 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 claims description 2
- 238000005370 electroosmosis Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 3
- 230000003292 diminished effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000005670 electromagnetic radiation Effects 0.000 claims 1
- 230000000063 preceeding effect Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 230000003319 supportive effect Effects 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000007800 oxidant agent Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 abstract 4
- 210000003722 extracellular fluid Anatomy 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 19
- 229930003268 Vitamin C Natural products 0.000 description 19
- 235000019154 vitamin C Nutrition 0.000 description 19
- 239000011718 vitamin C Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 4
- 230000008693 nausea Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 238000011514 vinification Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A mixture for application to humans and other species internally and externally to augment one of the body's disease combating agents, which should be present in the intercellular fluid of an adequately nourished body when its defence system has been alerted, comprising dilute hydrogen peroxide (oxidant, identical to that generated naturally within body cells for oxidising food and released into their environs to eliminate attacking organisms) and ascorbic acid (antioxidant, utilised by healthy body cells to protect themselves against internal oxidation during metabolism and their outer membranes after the hydrogen peroxide release action) in proportions which produce a neutral (non-oxidising) substance that after introduction into the intercellular fluid is separated as required by healthy body cells which absorb the ascorbic acid component for their own protection whilst unleashing the hydrogen peroxide component to destroy disease causing organisms which cannot resist oxidation as successfully as healthy body cells can.
Description
AN AID TO RECOVERY FROM DISEASE
CAUSED BY BACTERIA,FUNGI,
VIRUSES AND MALIGNANT CELLS
This invention relates to assisting humans, animals and birds to resist infections and recover from disease.
It has been known for many decades that humans and other species of complex multi-celled creatures have within their bodies systems for their defence against harmful bacteria, fungi, viruses and body cells which have become malignant.
Invasive micro-organisms of this kind may if not checked lead a parasitic existence and multiply within and/or upon bodies, causing disease.
Body defence systems generally aim to destroy alien micro-organisms and anomalous cells without harming healthy body cells. This is attempted by several different means including, at an early stage after detection of hostile organisms, the addition of substances to the inter-cell fluid which the said organisms cannot tolerate to the degree that the healthy body cells can. Because the harmful micro-organisms have to encounter the inter-cell fluid to multiply and extend the infection, disease is normally averted at this early stage by the stated prompt action of the defence system, before it becomes necessary to put any of the body's other more elaborate remedial methods into action and without the manifestation of symptoms.
One of the substances known to be generated within the body and added to the inter-cell fluid soon after the body defence system has been alerted is hydrogen peroxide, a powerful oxidising agent. The concentration level of hydrogen peroxide in the inter-cell fluid is regulated by the body to be as high as possible without risking damage to normal healthy body cells and friendly bacteria, which are able to protect themselves, up to a limit, against oxidation by utilising natural antioxidants, an ability not possessed, or possessed to a much lesser extent by harmful bacteria and fungi, viruses and malignant cells.
The main antioxidant utilised by healthy body cells for their own protection against oxidation damage is ascorbic acid, also called vitamin C. A small but regular supply of this vitamin is essential to the body cells, of warm blooded creatures, which they use to protect their structures against oxidation damage during their normal continuous function of oxidising nutrients to generate heat.
The primates are known to differ from other species in that their bodies cannot synthesise vitamin C, meaning that all the vitamin C they need has to be ingested. In normal health this essential minimum quantity of vitamin C should be obtained from the diet, but when a human is infected by a virus for example, frequent doses of vitamin C several orders of magnitude above the normal minimum requirement have been proved to strengthen the body's resistance to the viral infection and accelerate recovery.
Up to a limit, the more vitamin C there is available for use by the healthy body cells the higher their tolerance of hydrogen peroxide, and consequently the higher the body can safely raise the concentration of this substance in the intercell fluid, to maximise the damage to offensive organisms by oxidation without harming itself. A mechanism within the body appears to sense the vitamin C concentration in the inter-cell fluid and adjust the hydrogen peroxide concentration accordingly, any excess being rapidly converted into oxygen and water by special enzymes. This fact probably, at least in part, explains the observed beneficial effect of taking large doses of vitamin C when our bodies are fighting infections such as the common cold and influenza.
A case of illness may indicate either that the body defence system failed to detect disease-causing organisms, or that it was alerted but could not generate hydrogen peroxide due to some defect or shortage, or that its action had to be suspended to avoid damage to healthy body cells inadequately supplied with vitamin C to protect themselves against peroxidation. It follows therefore that there must be sufficient vitamin C in the body's inter-cell fluid before hydrogen peroxide therapy can be applied by the body itself in the natural way or by clinical intervention.
Hydrogen peroxide, as generated within the body naturally for its defence has also been produced artificially and widely used in many fields of technology. Its germicidal properties have also been known for centuries. Solutions of hydrogen peroxide have been used to treat external wounds, gum disease etc., as well as to sterilise baby feeding bottles, wine making equipment and surgical instruments.
In 1920 hydrogen peroxide in a very diluted form was reported to have been injected into patients suffering from a life threatening viral epidemic at a hospital in France, with dramatic positive results.
In more recent times there has been experimental work done with animals and humans, confirming the significant therapeutic value of hydrogen peroxide when given in controlled doses by injection, infusion and/or by mouth. The therapy has been claimed by some to be effective against all known kinds of viruses, harmful bacteria and malignant cells.
The taking of a suitably dilute solution of hydrogen peroxide by mouth in carefully measured and regulated doses is nowadays practised by many people with considerable evidence for the curative efficacy of the treatment against a wide range of illnesses.
A disadvantage of taking hydrogen peroxide solution by mouth, which is a convenient method of self treatment, is that it reacts with stomach contents, causing nausea in most people as well as losing some of its potency before absorption into the bloodstream. Although this effect can be minimised by taking the hydrogen peroxide solution on an empty stomach and by building up to the maximum recommended dose gradually over several days or weeks, many people still suffer some nausea, and the need for the gradual build-up to maximum dose means a delay in obtaining full impact of the treatment.
A disadvantage when hydrogen peroxide is injected or infused into the blood is that the previously mentioned enzymes are triggered into action by the excessive peroxide to vitamin
C ratio at and near to the application point, leading to a rapid conversion of the peroxide to prevent damage to healthy body cells as explained earlier. The result is that only a small proportion of the hydrogen peroxide administered survives to be effectively circulated through the body. This problem cannot be solved by increasing the strength of the injected or infused solution beyond the capability of the corrective enzymes as healthy body cells would then be damaged.
The present invention allows the maximum recommended dose of hydrogen peroxide in solution to be taken orally without the previously required build-up period, and without causing significant nausea regardless of stomach contents, thus enabling the therapy to be applied swiftly with maximum effect as soon as symptoms are felt. Also,it ensures that hydrogen peroxide infused or injected into the blood is not quickly removed by enzyme action as stated, before circulating and diffusing throughout the body as required.
The principle of the present invention was conceived after realising that vitamin C and hydrogen peroxide mix naturally by chance in the inter-cell fluid of the body without any apparent adverse reaction, and predicting that adding vitamin C as ascorbic acid to a given hydrogen peroxide solution would diminish its oxidising power, reducing it to zero if sufficient was added. Such a solution of hydrogen peroxide in water neutralised by the addition of ascorbic acid was later proved to have no oxidising effect when brought into contact with materials which include body tissue, gastric juices and food. This solution may therefore be ingested without causing nausea, for efficient absorption into the body's bloodstream and delivery to the inter-cell fluid, where it is separated into its two original components by the healthy body cells which absorb the vitamin C component for their own protection against oxidation whilst releasing the hydrogen peroxide component to destroy invasive harmful organisms including viruses and malignant body cells as required.
Whereas the benefit of ingesting the minimum daily requirement of vitamin C separately during hydrogen peroxide therapy has been recognised in the past, and that hydrogen peroxide solutions have been taken orally mixed with fruit and/or vegetable juices, naturally containing small amounts of vitamin C, the novelty of the present invention is in that the oxidising power of the hydrogen peroxide solution is deliberately neutralised by the direct addition of sufficient ascorbic acid to it before introducing it to the body, minimising unwanted reactions when the mixture is taken by mouth and ensuring full potency combined with protection against oxidation damage to normal healthy body cells when applied to the body by any chosen method including injection, ingestion, infusion, the bathing of body surfaces including scalp and body orifices and/or by inhalation of the mixture as drops and/or spray into nasal cavities and lungs, all in controlled suitable doses and strengths.
According to this invention there are provided solutions of hydrogen peroxide to which at least sufficient ascorbic acid has been added to reduce the oxidising power of the mixtures to zero or near zero for application, after further dilution if deemed necessary, externally and/or internally by ingestion, infusion, injection and/or inhalation to the bodies of humans and other creatures in regulated suitable solution strengths and doses for the purpose of preventing, or arresting and eliminating the parasitic existence of viruses and harmful bacteria and fungi and malignant cells.
Whereas the embodiment of the present invention always comprises a mixture of hydrogen peroxide and ascorbic acid in relative proportions which render the oxidising power of the said mixture at or near zero, the strength of the solution provided, here defined as the quantity of hydrogen peroxide per unit weight of solvent which is preferably water, may be varied. The mixtures as specified may be provided at strengths suitable for direct application or as stronger solutions requiring to be diluted to suit a particular person or creature to be treated and depending on the method of administration.
The amount of a chosen strength of solution, as defined above, given/taken per dose and the frequency of dosing may also be varied for optimum results in a particular case. Determination of the maximum strength of solution and dosage to be generally recommended will inevitably require cautious extensive trials, but by way of example of the embodiment of the present invention mixtures as successfully used by the inventor and a few other people over a two year test period are given. In these tests, administration of the mixture was confined to ingestion, inhalation and application to external body surfaces and mouth.
For the treatment of common cold and influenza type symptoms a mixture comprising 2.5 millilitres of 18% strength hydrogen peroxide and 2.5 grammes of ascorbic acid in approximately 250 millilitres of water or fruit juice was taken, at most three times, spaced four hours apart, for complete elimination of the symptoms. The same strength of mixture was taken three times per day for eight weeks to alleviate severely painful body joints.
For application to external body surfaces including scalp(for the elimination of dandruff), as a mouth wash (to treat ginivitis etc.), for the elimination of common warts and fungal infections such as 'athlete's foot' and also for minor cuts and scratches the mixture used comprised 5 grammes of ascorbic acid and 5 millilitres of 18% strength hydrogen peroxide per 250 millilitres of water. This mixture was applied at least once per day or as felt necessary.
For the relief of nasal and bronchial congestion the mixture used comprised 1.25 grammes of ascorbic acid and 1.25 millilitres of 18% strength hydrogen peroxide per 250 millilitres of water.
This mixture was inhaled as a fine spray as required.
Without departing from the principle of the present invention, other substances may be added to the specified mixtures of hydrogen peroxide neutralised with vitamin C to affect its colour and/or taste. Also, without departing from the principle of this invention dry substances and/or ozone which produce hydrogen peroxide on mixing with water may be combined with sufficient ascorbic acid to render the oxidising power of the final mixture at or near zero for medicinal use as described earlier in this specification.
Also, in the knowledge that water when irradiated with ultra-violet light and other shorter wavelength electromagnetic rays is partially converted into hydrogen peroxide, the present invention may include the provision of a container, incorporating a suitable radiation source such as an ultraviolet lamp, into which a solution of vitamin C in water is placed for irradiation at a known intensity for a prescribed period to yield a hydrogen peroxide/vitamin C mixture of required strength for medicinal use as previously described in this specification.
The mixture specified here comprising a solution of hydrogen peroxide neutralised with ascorbic acid as described above may, in addition to the methods of administration already mentioned, be introduced to the inside of the body through unbroken skin by electro-osmosis. This technique requires at least partial immersion of the body to be treated in the specified mixture, of suitable strength, whilst a very small direct electric current is passed between the body and the said mixture in the direction that assists diffusion of the mixture into the body.
Claims (8)
- AN AID TO RECOVERY FROM DISEASE CAUSED BY BACTERIA, FUNGI,VIRUSES AND MALIGNANT CELLS CLAIMS 1.A mixture for aiding recovery from disease in humans and other species comprising a solution of hydrogen peroxide and ascorbic acid in such relative quantities or proportions that the oxidising power of the former is very much diminished or preferably cancelled completely by the latter producing a liquid which after application internally and/or externally to a body enters the fluid surrounding the cells of which that body is constituted, for separation into the two original components in a controlled manner by healthy body cells which absorb the ascorbic acid component for their own protection against oxidation damage whilst releasing the hydrogen peroxide component within their surrounding fluid to eliminate hostile organisms including bacteria, viruses, fungi, and malignant cells which are more vulnerable to oxidation damage than healthy body cells.
- 2.A mixture as stated in Claim 1 which when introduced to a sick body by ingestion, injection, infusion, electro-osmosis, skin or wound cotact enters that body's inter-cell fluid to augment the nearly identical mixture which the healthy adequately nourished body provides therein when that body's defence system has successfully detected invasive organisms and caused its cells to discharge some of the hydrogen peroxide which they normally generate within themselves, for use in their metabolic process, into the fluid surrounding them, provided there is sufficient ascorbic acid present in the inter-cell fluid for the protection of the healthy cells' outer membranes from the oxidising action of the hydrogen peroxide whilst the said invasive organisms are killed by oxidation as they attempt to cross the inter-cell fluid to extend the infection.
- 3.A mixture based upon the principle stated in Claim 1 with other substances added to affect its colour and/or taste.
- 4.A mixture based upon the principle stated in Claim 1 to which other substances have been added as body nutrients, beneficial trace elements and/or drugs which may provide a parallel supportive action for restoring health.
- 5.The two components of the mixture as stated in Claim 1 packaged separately in the correct quantities and proportions for convenient combination into the specified mixture by addition to a suitable quantity of water or other preferred liquid for applying to the body internally and/or externally in a prescribed manner.
- 6.A prurality of the twin packages of Claim 5 for conveniently providing multiple single doses of the mixture to be prepared.
- 7.Apparatus for synthesising the mixture as stated in Claim 1 by exposing a quantity of water with added ascorbic acid and naturally dissolved oxygen to ultraviolet light or other electromagnetic radiation for a specified period.
- 8.A mixture as claimed in any of the preceeding Claims which includes a solution of hydrogen peroxide and ascorbic acid in relative quantities that provide a liquid of very low oxidising power for application to humans and other species in suitable doses by any preferred means to enter the fluid between body cells and be separated by the said cells into the original two components gradually, the ascorbic acid component being utilised by the healthy cells to resist damaged to themselves by the oxidising action of the hydrogen peroxide component whilst invasive hostile organisms which cannot resist oxidation are being destroyed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9325804A GB2285218A (en) | 1993-12-17 | 1993-12-17 | An aid to recovery from disease caused by bacteria fungi viruses and malignant cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9325804A GB2285218A (en) | 1993-12-17 | 1993-12-17 | An aid to recovery from disease caused by bacteria fungi viruses and malignant cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9325804D0 GB9325804D0 (en) | 1994-02-23 |
| GB2285218A true GB2285218A (en) | 1995-07-05 |
Family
ID=10746748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9325804A Withdrawn GB2285218A (en) | 1993-12-17 | 1993-12-17 | An aid to recovery from disease caused by bacteria fungi viruses and malignant cells |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2285218A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996034612A1 (en) * | 1995-05-05 | 1996-11-07 | Promex Investments Limited | Compositions for the treatment of infections caused by hiv, aids and lymphomas using hydrogen peroxide |
| WO2002064151A1 (en) * | 2001-02-09 | 2002-08-22 | Physician's Choice Of Arizona, Inc. | Acrochordon alleviation |
| US7381427B2 (en) | 2001-02-09 | 2008-06-03 | Mickey Miller | Seborrheic keratosis treatment |
| EP2276505A4 (en) * | 2008-03-20 | 2011-06-22 | Krister Tano | Use of a substance for manufacturing of a medicament for treatment of common cold |
| WO2015149946A1 (en) * | 2014-04-02 | 2015-10-08 | Merz Pharma Gmbh & Co. Kgaa | In vivo degradation of polysaccharide-containing fillers |
| US9675639B2 (en) | 2014-04-21 | 2017-06-13 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380764A (en) * | 1989-06-08 | 1995-01-10 | Herzog; Paul | Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use |
-
1993
- 1993-12-17 GB GB9325804A patent/GB2285218A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380764A (en) * | 1989-06-08 | 1995-01-10 | Herzog; Paul | Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use |
Non-Patent Citations (2)
| Title |
|---|
| Chemical Abstacts 87:195396 & Vidya, B, 20(1) pages 7-18 (1977) * |
| Chemical Abstracts 71:28113 & J. Bacteriol. 98(3) pages 949-955 (1969) * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996034612A1 (en) * | 1995-05-05 | 1996-11-07 | Promex Investments Limited | Compositions for the treatment of infections caused by hiv, aids and lymphomas using hydrogen peroxide |
| WO2002064151A1 (en) * | 2001-02-09 | 2002-08-22 | Physician's Choice Of Arizona, Inc. | Acrochordon alleviation |
| US7138146B2 (en) | 2001-02-09 | 2006-11-21 | Mickey Miller | Acrochordon alleviation |
| US7381427B2 (en) | 2001-02-09 | 2008-06-03 | Mickey Miller | Seborrheic keratosis treatment |
| CN100508990C (en) * | 2001-02-09 | 2009-07-08 | M·米勒 | Acrochordon alleviation |
| US8895282B2 (en) | 2008-03-20 | 2014-11-25 | Tanomed Ab | Use of a substance for manufacturing of a medicament for treatment of common cold |
| EP2276505A4 (en) * | 2008-03-20 | 2011-06-22 | Krister Tano | Use of a substance for manufacturing of a medicament for treatment of common cold |
| WO2015149946A1 (en) * | 2014-04-02 | 2015-10-08 | Merz Pharma Gmbh & Co. Kgaa | In vivo degradation of polysaccharide-containing fillers |
| US10413491B2 (en) | 2014-04-02 | 2019-09-17 | Merz Pharma Gmbh & Co. Kgaa | In vivo accelerated degradation of polysaccharide-containing fillers |
| US9675639B2 (en) | 2014-04-21 | 2017-06-13 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
| US9980983B2 (en) | 2014-04-21 | 2018-05-29 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
| US10098910B2 (en) | 2014-04-21 | 2018-10-16 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
| US10493103B2 (en) | 2014-04-21 | 2019-12-03 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
| US10653721B2 (en) | 2014-04-21 | 2020-05-19 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
| US10729720B2 (en) | 2014-04-21 | 2020-08-04 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9325804D0 (en) | 1994-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6620379B1 (en) | Apparatus and method of treatment of wounds, burns and immune system disorders | |
| EP0732927B1 (en) | Compositions containing in particular, riboflavin, for the local prevention of diseases of the genital and rectal mucus membranes | |
| US20090227523A1 (en) | Use of compatible solutes as substances having free radical scavenging properties | |
| Weber et al. | Successful reduction of SARS-CoV-2 viral load by photodynamic therapy (PDT) verified by QPCRâ � � a novel approach in treating patients in early infection stages | |
| Hoffmann | Water-filtered infrared-A (wIRA) in acute and chronic wounds | |
| GB2285218A (en) | An aid to recovery from disease caused by bacteria fungi viruses and malignant cells | |
| RU2114646C1 (en) | Method of enhancement of organism protective property at effect of external physical factors | |
| Jani et al. | Ozone therapy: the alternative medicine of future | |
| Gonzalez et al. | Increasing the Effectiveness of Intravenous Vitamin C as an Anticancer Agent. | |
| CN111840448B (en) | Preparation method and application of anti-chapping compound traditional Chinese medicine liposome | |
| RU2019180C1 (en) | Remedy for treatment of hypodermic fibrosarcoma and method of its preparation | |
| US20080038376A1 (en) | Anti-cancer composition and method for using the same | |
| Hamidi | Comparison of Continuous and Intermittent Phototherapy in the Treatment of Toxic Neonatal Jaundice: A Double-blind Clinical Trial. | |
| CN1047521C (en) | Medicinal preparation for preventing and treating skin diseases | |
| Braye et al. | Extensive burns caused by the abusive use of photosensitizing agents | |
| CN117482134B (en) | Anti-radiation and anti-oxidation essential oil composition and preparation method and application thereof | |
| Weber et al. | Combination of Photodynamic Therapy and Multi-Wavelengths Photobiomodulation in Chronic Wound Healing Disorders: Case series | |
| CN110812378A (en) | Quaternary ammonium salt ozone oil and preparation method thereof | |
| KR20150059872A (en) | Crude vegetable material as a main material composition and manufacturing method and athlete's foot treatment | |
| KR101711004B1 (en) | Kit comprising anti-trouble composition and portable apparatus having a heat source united with a light irradiation and the method for improving skin beauty using the same | |
| JPH08337520A (en) | Curing method for dermatitis | |
| RU2357747C1 (en) | Method of psoriatic disease treatment | |
| RU2122418C1 (en) | Agent for treatment of patients with chronic hepatitis of an infectious etiology | |
| Gujral et al. | Ozone therapy: a milestone in the treatment of ailments | |
| Karatieieva et al. | Application of ozone therapy in surgical practice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |